Krystal Biotech targets global VYJUVEK expansion with Italy launch in H2 2026 while maintaining 90%–95% gross margin outlook [Seeking Alpha]
Krystal Biotech, Inc. (KRYS)
Last krystal biotech, inc. earnings: 11/4 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.krystalbio.com/investors
Company Research
Source: Seeking Alpha
Krish Krishnan, CEO, stated Krystal Biotech "made meaningful progress across all geographies" in 2025, with added U.S. sales capacity, accelerated demand, and international expansion. The company signed distributor agreements covering over 20 countries and aims to expand to more Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up Quick Insights International expansion, especially in Europe and Japan, will lead revenue growth as ex-U.S. becomes the predominant growth driver, while U.S. demand continues to accelerate. Pricing negotiations in Germany and France cause potential delays and accrual-based revenue recognition, impacting timing but not long-term revenue upside once finalized. Risks include non-linear overseas revenue tracking due to pricing negotiations, accrual timing, and Japan's first-year prescription rules possibly affecting compliance. Re
Show less
Read more
Impact Snapshot
Event Time:
KRYS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KRYS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KRYS alerts
High impacting Krystal Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
KRYS
News
- Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Chardan Capital from $220.00 to $323.00. They now have a "buy" rating on the stock.MarketBeat
- Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Krystal Biotech Inc (KRYS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]Yahoo! Finance
- Krystal Biotech, Inc. (KRYS) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Krystal: Profitable Growth And The Expanding Reach Of HSV-1 Technology [Seeking Alpha]Seeking Alpha
KRYS
Earnings
- 2/17/26 - Beat
KRYS
Sec Filings
- 2/17/26 - Form 8-K
- 2/17/26 - Form 10-K
- 2/11/26 - Form 4
- KRYS's page on the SEC website